click here to read full article
Read More
Category: Uncategorized
Dr. Steven Chatfield joins the Stablepharma Advisory Board
Stablepharma listed in ‘Who are the UK’s leading startups making waves in impact investing? by FinMag
The United Kingdom is a hub for innovative startups and companies in the realm of impact investing, a variety of investing that seeks to generate both financial return and social or environmental good. Impact investing is fast gaining traction as we move towards a more responsible and sustainable way of doing business. It aligns money […]
Read More
Fridge-free vaccines could greatly expand access worldwide – University Hospital Southampton (UHS)
Researchers at University Hospital Southampton (UHS) are working with Stablepharma Ltd to trial vaccines that don’t need to be kept cold. The partners have been awarded a joint grant by Innovate UK to develop a fridge-free vaccine, SPVX02, to prevent tetanus and diphtheria.
Read More
Innovate UK awards Stablepharma a second grant to advance fridge-free vaccines
Stablepharma Ltd, the Fridge-free Vaccine Company, has been awarded a second Innovate UK Grant, in partnership with University Hospital Southampton NHS Foundation Trust, as it commences a bridge-funding round in Q4 2023. This joint Innovate UK grant will advance the clinical development of Stablepharma’s lead candidate, SPVX02, a fridge-free vaccine for the prevention of Tetanus […]
Read More
Wealth Briefing reports on new Advisory Board Members Joining Stablepharma Ltd
Dr Ceri Morgan and Richard Lane join the Stablepharma Ltd Advisory Board at a time of growth and investment. Stablepharma Ltd is delighted to announce two new members who will join the Advisory Board with immediate effect – Richard Lane, an experienced corporate lawyer and Dr Ceri Morgan, Senior Advisor & NED, specialising in capital […]
Read More
Stablepharma sign a second exclusive supply agreement to develop a fridge-free Tetanus vaccine
Stablepharma Ltd, the Fridge-free Vaccine Company and BB-NCIPD Ltd (Bul Bio) European vaccine manufacturer, have signed a second agreement for the exclusive bulk supply and commercialisation of the Tetanus vaccine (SPVX06). This agreement follows a similar arrangement with Bul Bio for the Tetanus diphtheria vaccine (SPVX02) in September 2022. “As a result of this strategic […]
Read More
Lorena Carmona Rodriquez as Senior Scientist to specifically progress mRNA-LNP programme.
Stablepharma Ltd is delighted to announce that Lorena Carmona-Rodiguez is joining the Science Team at our R&D Centre in Madrid, Spain. Lorena joins ‘The Fridge-free Vaccine Company’ as Senior Scientist to specifically progress our mRNA-LNP programme. Lorena has a Master’s Degree and PhD in Molecular Biosciences from the Universidad Autónoma de Madrid. She was, until […]
Read More
Martin Powell RIP 1956 – 2023
It is with great sadness and regret that the Board of Stablepharma has to announce the unexpected passing of Martin Powell on the 1st of May 2023. As our colleague and fellow Director, Martin was someone who made substantial contributions to the company since the early days and we will all miss his company, enthusiasm […]
Read More
Professor Saul Faust, Advisory Board Member of Stablepharma, receives OBE at Buckingham Palace
Professor Saul Faust, consultant paediatrician at University Hospital Southampton, has been recognised for his research into vaccines which helped determine how safe and effective they were before being rolled out. He was presented the accolade by the Prince of Wales last week after it was announced last year in the Queen’s Jubilee Honour’s List. Southampton […]
Read More